Table 2.
Distribution of hr-HPV genotypes in invasive cervical cancer patients stratified by HIV status (n = 126)
| Characteristic | HIV-uninfected n = 38 | HIV-infected n = 88 | p-value1 |
|---|---|---|---|
| HPV genotypes | |||
| HPV-16 alone | 13 (34.2%) | 42 (47.7%) | N/A2 |
| HPV-16 and HPV-18 | 6 (15.8%) | 12 (13.6%) | |
| HPV-16 and other hr-HPV | 3 (7.9%) | 11 (12.5%) | |
| HPV-16, HPV-18 and other hr-HPV | 2 (5.3%) | 6 (6.8%) | |
| HPV-18 alone | 3 (7.9%) | 6 (6.8%) | |
| HPV-18 and other hr-HPV | 1 (2.6%) | 0 (0%) | |
| Other hr-HPV (non-16 or non-18) | 10 (26.3%) | 11 (12.5%) | |
| HPV genotypes (HPV-16 alone or multiple) | |||
| HPV-16 alone | 13 (34.2%) | 42 (47.7%) | 0.160 |
| Others | 25 (65.8%) | 46 (52.3%) | |
| HPV genotypes (non-16/non-18 or multiple) | |||
| hr-HPV (non-16 or non-18) | 10 (26.3%) | 11 (12.5%) | 0.056 |
| Others | 28 (73.7%) | 77 (87.5%) | |
| HPV genotypes (alone or multiple) | |||
| HPV-16 or HPV-18 alone | 16 (42.1%) | 48 (54.5%) | 0.629 |
| Multiple hr-HPV genotypes | 12 (31.6%) | 29 (37.7%) | |
| HPV genotypes (HPV-16 or HPV-18 present) | |||
| HPV-16 present | 24 (63.2%) | 71 (80.7%) | 0.036 |
| HPV-18 present | 12 (31.6%) | 24 (27.3%) | 0.623 |
1
Based on Chi-squared test.
2
Statistics were not calculated due to insufficient data counts.